BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. BIOLASE’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. BIOLASE is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.

Irvine, US
200 (est)-4%
Biolase was founded in 1987 and is headquartered in Irvine, US

Key People at Biolase

Jeffrey Nugent

Jeffrey Nugent

President and Chief Executive Officer
Dmitri Boutoussov

Dmitri Boutoussov

Frederick D. Furry

Frederick D. Furry

Chief Financial Officer
Alexander K. Arrow

Alexander K. Arrow

Chief Medical Officer
William E. Brown

William E. Brown

VP, Business Development
Colleen M. Boswell

Colleen M. Boswell

Vice President, Regulatory Affairs and Quality Assurance

Biolase Locations

Irvine, US
Albany, US
Columbus, US
New York, US
Jacksonville, US
Seattle, US
Miami, US
Denver, US
San Ramon, US

Biolase Metrics

Biolase Summary

Market capitalization

$102 M

Closing share price

Biolase's current market capitalization is $102 M.

Biolase Financials

Biolase's revenue is $56.4 M in FY, 2013
FY, 2013


$56.4 M

Gross profit

$21.5 M

Operating income

$-11 M

Operating expense total

$32.5 M

Net Income

$-11.5 M

Operating cash flow

$-1.1 M

    Biolase Market Value History

    Biolase Online Presence

    Biolase Company Life

    You may also be interested in